Vanderbilt Ingram Cancer Center Archives
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.
Feb. 9, 2023—Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
Feb. 6, 2023—Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
Jan. 19, 2023—Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
Dec. 5, 2022—KarenWinkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance, has been named one of three new members of the American Cancer Society Cancer Action Network’s national board of directors.
Nov. 30, 2022—R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center and surgeon-in-chief of Vanderbilt University Hospital, died Nov. 27 at Alive Hospice. He was 66 years old.
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Nov. 16, 2022—Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.